Is It Time to Reexamine the Role of Anti-TNFs in the IBD Landscape?

Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Jeffrey Basile, MD

Now that we have therapies like vedolizumab and ustekinumab, many are wondering if there’s still a role for anti-TNFs in the treatment of IBD. Here to share his perspective and how he uses the multitude of available treatment options to his advantage is Dr. Jeffrey Basile, a gastroenterologist from Charleston GI.